About Cala Health
Cala Health is a medical device company that has developed the Cala kIQ System, the only FDA-cleared wearable device for treating action hand tremor in people with essential tremor and Parkinson's disease. The company's proprietary TAPS (Transcutaneous Afferent Patterned Stimulation) therapy delivers individualized, non-invasive neuromodulation through a wrist-worn device. The technology works by sensing each patient's unique tremor signature and delivering personalized electrical stimulation through the nerves from the wrist to the brain to counteract tremor. Clinical studies demonstrate that 9 out of 10 people experience tremor reduction with a complete 40-minute session, with relief lasting over 90 minutes on average after treatment. The therapy is physician-prescribed and can be used multiple times daily, on-demand before activities affected by tremor such as eating, writing, or drinking. Cala Health's solution addresses the needs of over 7 million Americans struggling with essential tremor, offering a safe alternative that can be used alongside medications or when medications are not meeting patient needs. The company provides patients with data insights through the MyCala patient portal, allowing them to track results over time and share reports with healthcare providers. The Cala kIQ System is covered by Medicare for qualifying beneficiaries, the VA for veterans, and many commercial insurance plans.
Clinical Focus
Medical conditions and clinical areas addressed by Cala Health.
Who It Serves
Milestones & Awards
Recent Milestones
Medicare coverage approved for qualifying beneficiaries (2024-2025 timeframe based on website messaging). Multiple peer-reviewed publications in 2022-2023 including largest prospective device study in essential tremor (N=310) and long-term real-world evidence up to 3.4 years of use.
Key Partnerships
Company Details
Work here?
Claim this listing to update company information and connect with our audience.
Claim This ListingSecurity & Compliance
Official Sources
Similar Companies in this Market
View all 46 →
Abbott Diabetes Care
Abbott Diabetes Care develops FreeStyle Libre, a world-leading continuous glucose monitoring (CGM) portfolio for diabetes management with advanced analytics and innovation.
Amalgam Rx
Amalgam Rx develops AI-powered digital therapeutics and Software as a Medical Device (SaMD) solutions for chronic disease management. The company partners with life sciences companies, health plans, and providers to deliver regulated digital health applications and EHR-integrated clinical decision support tools.
Arkray
ARKRAY USA manufactures and distributes blood glucose monitoring systems, clinical diagnostic equipment, and oral wellness products. The company serves consumers with diabetes, healthcare professionals, and clinical laboratories with accurate, affordable diagnostic solutions.
BeatO
BeatO is a digital health platform specializing in diabetes management and weight loss solutions. The company offers smart glucose monitoring devices, GLP-1 weight loss programs, and a comprehensive diabetes care program combining connected devices, doctor consultations, and health coaching for over 2 million patients across India.
Brook Health
AI-powered remote patient monitoring and chronic disease management platform for conditions like diabetes, hypertension, and heart disease.
Cadence
Cadence delivers AI-powered remote patient care programs for chronic disease management. The company partners with health systems, payers, and medical groups to provide 24/7 monitoring, medication management, and clinical support for patients with hypertension, heart failure, diabetes, and other chronic conditions.
Calibrate
Calibrate is a metabolic health company that combines clinician-prescribed GLP-1 medications with 1:1 video coaching and science-backed curriculum to help members achieve sustainable weight loss. Members lose an average of 19% of their body weight achieved over three years.
Cecelia Health
Cecelia Health is a national virtual specialty medical practice providing clinician-led integrated cardiometabolic care. The company delivers coordinated treatment for obesity, diabetes, hypertension, chronic kidney disease, and other connected conditions through licensed clinicians including registered dietitians, nurses, and diabetes care specialists.
Data Accuracy Notice: Company information on HealthAI Central is compiled from public sources and updated regularly. While we strive for accuracy, details such as funding figures, employee counts, and product offerings may change. We recommend verifying critical information directly with the company before making business decisions.